Review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients

"We conclude that the current assessment of adverse drug events is hampered by the choice of methods."

A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients
L Hakobyan, FM Haaijer-Ruskamp, D de Zeeuw, D Dobre, P Denig
Health and Quality of Life Outcomes, 2011, 9:83

Read more here.